Skip to main content
Akzo Nobel N.V. logo

Akzo Nobel N.V. — Investor Relations & Filings

Ticker · AKZA ISIN · NL0013267909 LEI · 724500XYIJUGXAA5QD70 AS Manufacturing
Open in API
Filings indexed 952 across all filing types
Latest filing 2007-04-02 M&A Activity
Country NL Netherlands
Listing AS AKZA

About Akzo Nobel N.V.

https://www.akzonobel.com/en

Akzo Nobel N.V. is a global company specializing in the manufacturing of paints and coatings. With a history dating back to 1792, the company provides a wide range of products designed for both protection and color. Its portfolio includes decorative paints and performance coatings, such as liquid and powder coatings, for a variety of industries and applications. The company operates a world-class portfolio of brands, including Dulux, International, Sikkens, and Interpon, which are trusted by customers globally. AkzoNobel focuses on delivering innovative and sustainable solutions to sustain and enhance everyday life, driven by a commitment to pioneering new products and technologies.

Recent filings

Filing Released Lang Actions
Akzo Nobel divests Methylamines and Choline Chloride business to Balchem
M&A Activity Classification · 99% confidence The document is a press release announcing the sale of a business unit (Methylamines and Choline Chloride) by Akzo Nobel to Balchem Corporation. It details the strategic rationale, transaction parties, and mentions that regulatory approvals will be sought. It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a quarterly report (IR). It is an announcement concerning a major corporate transaction (divestiture/sale). While it relates to corporate activity, it most closely aligns with an announcement regarding a significant corporate action that impacts the structure or assets, which often falls under general corporate news or M&A activity. Since the core event is the agreement to sell a business, 'M&A Activity' (TAR) is the most appropriate category, even though it is a divestiture rather than an acquisition. Reviewing the definitions: - ER/IR: No, it's not financial results. - 10-K/AR: No, it's not the full annual report or audit. - CAP: It is a divestiture, which changes capital structure, but TAR (M&A Activity) is more specific for asset/business sales/purchases. - RNS: It could be RNS if TAR didn't exist, but TAR is a better fit for a business sale announcement. Therefore, classifying it as M&A Activity (TAR) due to the divestiture announcement.
2007-04-02 English
Akzo Nobel divests PVC additives business
Capital/Financing Update Classification · 95% confidence The document is a press release (persbericht) announcing the sale of Akzo Nobel's PVC additives business to a private investment firm. It contains no financial statements or detailed financial performance data. It is a corporate announcement about a transaction (divestiture) but does not provide comprehensive financial results or a report. The document length is 3992 characters, which is relatively short and consistent with a press release. There is no indication that this is a full annual report, interim report, earnings release, or any other detailed financial filing. It is not a regulatory filing or certification. The content fits best with a Capital/Financing Update (CAP) as it announces a significant transaction related to the company's business portfolio and strategic restructuring. Therefore, the appropriate classification is CAP with high confidence.
2007-03-15 English
Akzo Nobel divests PVC additives business
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the divestment of Akzo Nobel's PVC additives business to a private investment firm. It contains no financial statements, detailed financial performance data, or regulatory filings. It is a corporate announcement about a transaction (divestment) but does not detail financing activities like fundraising or capital structure changes. The document is short (3833 characters) and reads as a corporate media release about a business divestment. This fits best under Capital/Financing Update (CAP) as it relates to a significant change in the company's business portfolio through divestment. It is not an Annual Report, Earnings Release, or Regulatory Filing, nor is it a report publication announcement. Therefore, the appropriate classification is CAP with high confidence.
2007-03-15 English
"Historic joint launch for Akzo Nobel's flagship reports"
Report Publication Announcement Classification · 95% confidence The document is a press release from Akzo Nobel dated March 14, 2007, announcing the simultaneous publication of their annual report and Corporate Social Responsibility (CSR) report for the year 2006. It describes the contents and significance of both reports but does not contain the full annual report or CSR report itself. The document is about the announcement of the publication of these reports, not the reports themselves. The length is 6028 characters, which is relatively short and consistent with a press release or announcement rather than a full report. Therefore, according to the 'Menu vs Meal' rule, this document should be classified as a Report Publication Announcement (RPA).
2007-03-14 English
"Historic joint launch for Akzo Nobel's flagship reports"
Report Publication Announcement Classification · 95% confidence The document is a press release announcing the publication of Akzo Nobel's Annual Report and Corporate Social Responsibility (CSR) Report for 2006. It highlights the joint launch of these reports and provides an overview of their content and significance. The document does not contain the actual reports or detailed financial data but rather serves as an announcement of their availability. The text mentions that the reports are available online and provides a summary of their features. Given the document length (5592 characters) and its nature as a press release announcing the reports rather than the reports themselves, it fits the criteria for a Report Publication Announcement (RPA).
2007-03-14 English
Akzo Nobel Announces Intended Sale of Organon BioSciences to Schering-Plough for EUR 11 billion
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the intended sale of Akzo Nobel's subsidiary Organon BioSciences to Schering-Plough for EUR 11 billion. It discusses the transaction details, strategic rationale, and future plans including a share buy-back program. There are no financial statements or detailed financial performance data included. The document is an announcement of a major corporate transaction and capital structure update, not a full report or regulatory filing. Therefore, it fits best under Capital/Financing Update (CAP). The document length is sufficient and content is consistent with a financing/capital update announcement rather than a full annual or interim report or merger filing.
2007-03-12 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.